Pharmaceuticals, Biotechnology and Life Sciences
Apeiron Biologics AG has received regulatory approvals in Austria, Germany and Denmark to kickoff a Phase II clinical trial of APN01 to treat COVID-19.
Three leading biopharmaceutical companies have announced programs enabling employees with medical and laboratory expertise to volunteer their services to local…
German biopharmaceutical company InflaRx has enrolled the first patient into a randomized clinical trial investigating the safety and efficacy of IFX-1, the company´s monoclonal anti-C5a antibody, in patients with severe COVID-19-induced pneumonia.
DARTMOUTH, Nova Scotia–(BUSINESS WIRE)–IMV Inc. (Nasdaq: IMV) (TSX: IMV), a clinical-stage biopharmaceutical company (the “Company” or “IMV”), today provided updates…
Merck is Contributing 300,000 Masks to New Jersey’s Office of Homeland Security and Preparedness to Support COVID-19 Relief Efforts KENILWORTH,…
N4 Pharma will test a Covid-19 DNA plasmid if Nuvec, a novel delivery system for cancer treatments and vaccines, can be used as a delivery system by potential collaboration partners developing Covid-19 DNA or RNA vaccines.
Roche said Tuesday it started testing Actemra (tocilizumab) with the Biomedical Advanced Research and Development Authority (BARDA)on top of standard of care in hospitalised adult patients with severe COVID-19 pneumonia compared to placebo on top of standard of care.
WILMINGTON, Del.–(BUSINESS WIRE)–Ufovax, a spin-off vaccine company from Scripps Research, announced today that the company has successfully extended its patented…
European site enrollment concerns grow to 85% NORTHBROOK, Ill.–(BUSINESS WIRE)–#COVID19–Over the course of just one week, US clinical research study…
ObsEva CEO Ernest Loumaye s said the instituting new measures to support the priorities of safety to manage through the COVID-19 pandemic.